BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23

• Press Releases

  Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - October 16, 2026

  October 18, 2026

   · 

  2 min read
• Press Releases

  Korro Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - October 16, 2026

  October 18, 2026

   · 

  2 min read
• Press Releases

  Nanox Provides Business Update and Furnishes Certain Preliminary Unaudited Financial Data for Third Quarter Ended September 30, 2026

  October 18, 2026

   · 

  9 min read
• Press Releases

  4DMT Announces New Employment Inducement Grants - October 16, 2026

  October 18, 2026

   · 

  2 min read
• Press Releases

  Prelude Therapeutics to Participate in the Chardan Healthcare Conference 2026

  October 18, 2026

   · 

  1 min read
• Press Releases

  Viatris Receives U.S. FDA Approval for RYZUMVI® for the Treatment of Presbyopia

  October 18, 2026

   · 

  5 min read
• Press Releases

  Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - October 16, 2026

  October 18, 2026

   · 

  3 min read
• Press Releases

  Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - October 16, 2026

  October 18, 2026

   · 

  4 min read
• Press Releases

  Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4) - October 16, 2026

  October 18, 2026

   · 

  1 min read
• Press Releases

  SKYRIZI® (risankizumab) and RINVOQ® (upadacitinib) Data Highlight Long-Term Clinical and Endoscopic Outcomes Across Inflammatory Bowel Disease (IBD) at UEGW 2026

  October 18, 2026

   · 

  27 min read